STOCK-BASED AWARDS (Tables)

3 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement [Abstract]

A summary of stock option activity for the three months ended March 31, 2026 was as follows:


	Outstanding Options
	Number of Options	Weighted Average Exercise Price		Weighted-Average Remaining Contractual Term	Intrinsic Value (in thousands)
Balance as of December 31, 2025	2,030,874	$	19.09	3.98	$	2,918
Options exercised	(308,572)	8.93
Options canceled	(81,754)	48.01
Balance as of March 31, 2026	1,640,548	$	19.56	3.68	$	1,230
Options vested and exercisable as of March 31, 2026	1,561,157	$	17.27	3.63	$	1,230

Schedule of Restricted Stock Units Activity

A summary of RSUs activity for the three months ended March 31, 2026 was as follows:


	Restricted Stock Units
	Time-Based Shares	Performance-Based Shares	Total Shares	Weighted-Average Grant-Date Fair Value
Balance as of December 31, 2025	17,337,857	2,645,726	19,983,583	$	27.86
Granted	1,470,163	33,072	1,503,235	$	10.34
Vested	(2,111,155)	(466,775)	(2,577,930)	$	31.11
Cancelled/Forfeited	(555,566)	(656,568)	(1,212,134)	$	25.78
Balance as of March 31, 2026	16,141,299	1,555,455	17,696,754	$	26.04

Schedule of Stock-Based Compensation Expense

Total employee and nonemployee stock-based compensation expense for the three months ended March 31, 2026 and 2025, was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):


	Three Months Ended March 31,
	2026		2025
Cost of revenue	$	1,021	$	1,122
Research and development	37,685		34,821
Selling, general and administrative	23,683		(8,428)
Workforce reduction charges	(1,359)		—
Total	$	61,030	$	27,515